SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001493152-23-008251
Filing Date
2023-03-20
Accepted
2023-03-20 16:30:11
Documents
4

Document Format Files

Seq Description Document Type Size
1 formposam.htm POS AM 211766
2 ex23-1.htm EX-23.1 6737
3 logo.jpg GRAPHIC 8594
4 ex23-1_001.jpg GRAPHIC 9276
  Complete submission text file 0001493152-23-008251.txt   244443
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: POS AM | Act: 33 | File No.: 333-234292 | Film No.: 23746690
SIC: 2834 Pharmaceutical Preparations